계명대학교 의학도서관 Repository

The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients

Metadata Downloads
Author(s)
Moo Hyun LeeSo-Youn JungSun Hee KangEun Jin SongIn Hae ParkYoung Mee KwonKeun Seok LeeHan-Sung KangEun Sook LeeSun-Young Kong
Keimyung Author(s)
Lee, Moo HyunKang, Sun Hee
Department
Dept. of Surgery (외과학)
Journal Title
PloS One
Issued Date
2016
Volume
11
Issue
10
Abstract
Purpose;
This study evaluated the association of serum HER2 (sHER2) levels at diagnosis with clinicopathologic
parameters and disease free survival (DFS) in operable breast cancer
patients according to intrinsic subtype.
Results;
There were 436 consecutive stage I-III breast cancer patients with sHER2 result at diagnosis
between Nov 2004 and Dec 2011. High sHER2 levels ( 15 ng/ml) were reported in 52
patients (11.9%) and HER2 overexpression in tumor tissue was observed in 111 patients
(25.5%). High sHER2 levels were associated significantly with advanced stage (P < 0.001),
mastectomy (P = 0.012), neoadjuvant chemotherapy (P < 0.001), anti-HER2 therapy
(P < 0.001) and hormone therapy (P = 0.022). The patients with high sHER2 levels had a
worse DFS (P < 0.001). In multivariate analysis, high sHER2 levels were associated significantly
with worse DFS (HR = 2.25, 95% CI 1.27±3.99, P = 0.005). High sHER2 levels were
associated with worse DFS in the HR+/HER2-, HR+/HER2+ and HR-/HER2+ subtypes
(P = 0.043, 0.003 and 0.041, respectively).
Methods;
The sHER2 levels were measured using a chemiluminescence immunoassay. The HER2
status in all tumor tissues was determined by immunohistochemistry, and confirmed in
equivocal cases by fluorescence in situ. Conclusions;
These results show that the sHER2 level at diagnosis is a useful prognostic factor in
patients with operable breast cancer, especially in the HR+/HER2-, HR+/HER2+ and HR-/
HER2+ subtypes.
Keimyung Author(s)(Kor)
이무현
강선희
Publisher
School of Medicine
Citation
Moo Hyun Lee et al. (2016). The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients. PloS One, 11(10), e0163370–e0163370. doi: 10.1371/journal.pone.0163370
Type
Article
ISSN
1932-6203
DOI
10.1371/journal.pone.0163370
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/32548
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Surgery (외과학)
Authorize & License
  • Authorize공개
Files in This Item:

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.